These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 18069262)
61. Animal Models of Human Pathology 2016. Fedele M; Gualillo O; Vecchione A Biomed Res Int; 2016; 2016():4023982. PubMed ID: 28101508 [No Abstract] [Full Text] [Related]
62. Renal Lesions Associated with Multiple Myeloma. Bell ET Am J Pathol; 1933 Jul; 9(4):393-420.3. PubMed ID: 19970077 [No Abstract] [Full Text] [Related]
63. Severe combined immunodeficiency (SCID) mouse modeling of P-glycoprotein chemosensitization in multidrug-resistant human myeloma xenografts. Bellamy WT; Odeleye A; Huizenga E; Dalton WS; Weinstein RS; Grogan TM Clin Cancer Res; 1995 Dec; 1(12):1563-70. PubMed ID: 9815957 [TBL] [Abstract][Full Text] [Related]
64. LAGlambda-1: a clinically relevant drug resistant human multiple myeloma tumor murine model that enables rapid evaluation of treatments for multiple myeloma. Campbell RA; Manyak SJ; Yang HH; Sjak-Shie NN; Chen H; Gui D; Popoviciu L; Wang C; Gordon M; Pang S; Bonavida B; Said J; Berenson JR Int J Oncol; 2006 Jun; 28(6):1409-17. PubMed ID: 16685443 [TBL] [Abstract][Full Text] [Related]
65. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma. Tassone P; Neri P; Burger R; Savino R; Shammas M; Catley L; Podar K; Chauhan D; Masciari S; Gozzini A; Tagliaferri P; Venuta S; Munshi NC; Anderson KC Clin Cancer Res; 2005 Jun; 11(11):4251-8. PubMed ID: 15930364 [TBL] [Abstract][Full Text] [Related]
66. A bioluminescence imaging based in vivo model for preclinical testing of novel cellular immunotherapy strategies to improve the graft-versus-myeloma effect. Rozemuller H; van der Spek E; Bogers-Boer LH; Zwart MC; Verweij V; Emmelot M; Groen RW; Spaapen R; Bloem AC; Lokhorst HM; Mutis T; Martens AC Haematologica; 2008 Jul; 93(7):1049-57. PubMed ID: 18492693 [TBL] [Abstract][Full Text] [Related]
68. Mouse models of human myeloma. Mitsiades CS; Anderson KC; Carrasco DR Hematol Oncol Clin North Am; 2007 Dec; 21(6):1051-69, viii. PubMed ID: 17996588 [TBL] [Abstract][Full Text] [Related]
69. Mouse plasmacytoma: an experimental model of human multiple myeloma. Gadó K; Silva S; Pálóczi K; Domján G; Falus A Haematologica; 2001 Mar; 86(3):227-36. PubMed ID: 11255268 [TBL] [Abstract][Full Text] [Related]
70. The use of animal models in multiple myeloma. Libouban H Morphologie; 2015 Jun; 99(325):63-72. PubMed ID: 25898798 [TBL] [Abstract][Full Text] [Related]
71. The 5TMM series: a useful in vivo mouse model of human multiple myeloma. Asosingh K; Radl J; Van Riet I; Van Camp B; Vanderkerken K Hematol J; 2000; 1(5):351-6. PubMed ID: 11920212 [No Abstract] [Full Text] [Related]
72. Animal Models of Multiple Myeloma Bone Disease. Mehdi SH; Nafees S; Mehdi SJ; Morris CA; Mashouri L; Yoon D Front Genet; 2021; 12():640954. PubMed ID: 34163520 [TBL] [Abstract][Full Text] [Related]